𝔖 Bobbio Scriptorium

✦ LIBER ✦

Sequential proleukin (rIL-2) by continuous infusion with cisplatin and cyclophosphamide in patients with unresectable ovarian cancer

✍ Scribed by de Dycker, R.P.; Neumann, R.L.A.; Schumacher, T.; Heckmann, U.

Book ID: 123199201
Publisher: Elsevier Science
Year: 1991
Weight: 146 KB
Volume: 27
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(91)90194-I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 study of sequential neoadjuvan

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

✍ Julka, Pramod K.; Chacko, Raju T.; Nag, Shona; Parshad, Rajinder; Nair, Aravinda 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 244 KB

LTE—commenting on “Neoadjuvant chemother

LTE—commenting on “Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer” (90: 163–9): by Machiels et al. (, fax: +32-2-764-54-28)

✍ Scott M. Eisenkop 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Update of a randomized trial of cisplati

Update of a randomized trial of cisplatin (P) and cyclophosphamide (C) ± WR-2721 (WR) in patients with advanced ovarian cancer : McCulloch, W.1, Rose, P.2, Kemp, G.M.,3, Scheffler, B.1, Schein, P.1, 1U.S. Bioscience, W. Conshohocken, PA, 2University of Massachusetts, 3E. Virginia Med. School, USA

📂 Article 📅 1991 🏛 Elsevier Science ⚖ 178 KB